While it was demonstrated that colorectal tumor formation requires cleavage of IL-6R by ADAM17 to mediate soluble (s)IL-6R-dependent IL-6 trans-signaling [13,14], it further underlines the significance of ADAM17 in CRC pathology. The gene discussed is ADAM17; the disease is colorectal carcinoma.